NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Health Information Services · USD

LifeMD, Inc. (LFMD) Stock Analysis

LifeMD, Inc. (LFMD) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

LFMD

$3.08

+$0.03 (+0.98%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LFMD with… →

LFMD Key Statistics

As of Sep 4, 2026
Trading
Open
$3.03
Previous Close
$3.05
Day's Range
3.02–3.10
52-Week Range
2.56–7.32
Volume
604.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.04
Valuation
Market Cap
$148.46M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
8.11
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.77
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.53
Financials (FY)
Revenue (FY)
$194.06M+25.34%
Net Income (FY)
$14.35M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.10%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
48.20M
1-Year Return
−50.96%
Dividend and dates
Earnings Date
November 9, 2026estimated
Avg Volume
919.20K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LFMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−9.68%
2025−31.11%
2024−40.29%
2023+327.32%
2022−49.87%
2021−40.74%
2020+988.33%
2019−14.29%
2018−58.82%
2017+30.77%
2016 (partial year)+4.00%

As of September 4, 2026.

LFMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$194.06M$14.35M7.4%
2024$154.82M−$21.41M−13.8%
2023$152.55M−$20.60M−13.5%
2022$119.03M−$45.54M−38.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$194.06M$166.34M−$7.67M$14.35M7.4%
2024$154.82M$133.38M−$20.40M−$21.41M−13.8%
2023$152.55M$133.65M−$14.49M−$20.60M−13.5%
2022$119.03M$100.37M−$39.69M−$45.54M−38.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

LFMD Valuation vs Health Information Services Median

Median of 53 stocks
MetricLFMDHealth Information Services medianvs median
P/S ratio0.772.660.3x the median
Profit margin0.10%0.00%0.1 pts above

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 10 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values LifeMD, Inc. (LFMD) at $148.46M. It is classified in the Health Information Services industry, within the Healthcare sector. Headcount on file is 347.

Over the past 52 weeks the price has ranged from $2.56 to $7.32. The most recent close on file for LFMD is $3.08, dated September 4, 2026. That is +$0.03 (+0.98%) against the previous close. The latest close sits 20.31% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $194.06M. Against the prior fiscal year total of $154.82M, that is a change of +25.34%. Net income for the same year was $14.35M. Profit margin runs at 0.11%. That is 0.1 percentage points above the Health Information Services median of 0%. Earnings per share on a trailing basis come to −0.53.

Across the 4 fiscal years on file, revenue moves from $119.03M in 2022 to $194.06M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 8.11. The price-to-sales ratio is 0.77. On price-to-sales that is 0.3 times the Health Information Services median of 2.66. The medians here are taken across 53 Health Information Services companies that report the metric.

Over the trailing twelve months the price has returned −50.96%. Across 10 years the annualized return works out at +8.60%. The reported beta is 2.04. Daily returns over the trailing 10 years annualize to a volatility of 115.8%.

Growth & Income

The record shows no dividend for LFMD.

The strongest complete calendar year on file is 2020 at +988.33%; the weakest is 2018 at −58.82%. Of the 9 complete calendar years on file, 3 finished higher. 2026 is still running; the price is −9.68% year to date.

Peer Comparison

LifeMD, Inc. (LFMD) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
LifeMD, Inc. LFMD $148.46M —
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B —

The Health Information Services industry average P/E ratio is 41.1x. LifeMD, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

 BTSG

BrightSpring Health Services, Inc.

$12.02B

 TEM

Tempus AI, Inc.

$11.66B

 HQY

HealthEquity, Inc.

$7.95B

 HNGE

Hinge Health, Inc.

$7.45B

 WAY

Waystar Holding Corp.

$4.81B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About LifeMD, Inc.

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Visit website →